Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018158249) ROOM TEMPERATURE STABLE PHARMACEUTICAL COMPOSITION COMPRISING CARGLUMIC ACID
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/158249 International Application No.: PCT/EP2018/054808
Publication Date: 07.09.2018 International Filing Date: 27.02.2018
IPC:
A61K 9/20 (2006.01) ,A61K 31/198 (2006.01) ,A61P 43/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
195
having an amino group
197
the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid (GABA), beta-alanine, epsilon-aminocaproic acid, pantothenic acid
198
Alpha-amino acids, e.g. alanine, edetic acid (EDTA)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43
Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
Applicants:
DIPHARMA S.A. [CH/CH]; Piazza Col. C. Bernasconi 5 6830 Chiasso, CH
Inventors:
AGOSTINO GIAMMILLARI, Salvatore; IT
MACCARI, Giuseppe; IT
Agent:
TAGLIAFICO, Giulia; IT
Priority Data:
17000307.328.02.2017EP
Title (EN) ROOM TEMPERATURE STABLE PHARMACEUTICAL COMPOSITION COMPRISING CARGLUMIC ACID
(FR) COMPOSITION PHARMACEUTIQUE STABLE À TEMPÉRATURE AMBIANTE COMPRENANT DE L'ACIDE CARGLUMIQUE
Abstract:
(EN) The present invention relates to a highly room temperature stable drug dosage forms comprising a Carbamoyl Phosphate Synthetase 1 (CPS 1) activator susceptible to degradation, notably moisture-induced; and at least one pharmaceutically acceptable excipient.
(FR) La présente invention concerne des formes posologiques de médicament stables à température ambiante élevée comprenant un activateur de Carbamoyl Phosphate synthétase 1 (CPS 1) sensible à la dégradation, notamment induite par l'humidité; et au moins un excipient pharmaceutiquement acceptable.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)